1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA02454468
nvert pr=ferreds that I recommend buying. 3 EFTA_R1_01556244 EFTA02454470 Allergan (AGN) - BAML reaffirming BUY on AGN after the FTC approval of gener=cs sale to Teva. We like AGN due to its healthy product mix, solid pipe=ine and flexibility to deploy capital to drive shareholder return. N=xt catalys
No connected entities